Clinical trial
Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL)…
NCT00245271 · Omeros Corporation, Industry · Completed
Key facts
| NCT number | NCT00245271 |
|---|---|
| Title | Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction |
| Official title | Double-Blind, Multicenter Study Evaluating the Safety of OMS103HP and Vehicle in Subjects Undergoing Anterior Cruciate Ligament Reconstruction With an Open-Label Phase Containing a PK Analysis in a Subset of Subjects |
| Lead sponsor | Omeros Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anterior Cruciate Ligament Reconstruction |
| Intervention type | Drug |
| Interventions | OMS103HP, Vehicle |
| Enrollment | 480 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2011 |
| First posted | Oct 27, 2005 |
| Last update posted | Jun 27, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: